AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
56 hedge funds and large institutions have $101M invested in AVEO Pharmaceuticals, Inc. in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
Holders
56
Holding in Top 10
2
Calls
$3.14M
Puts
$376K
Top Buyers
| 1 | +$6.06M | |
| 2 | +$4.25M | |
| 3 | +$1.22M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.06M |
| 5 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$836K |
Top Sellers
| 1 | -$2.7M | |
| 2 | -$1.34M | |
| 3 | -$1.11M | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$395K |
| 5 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$320K |